AWM
ABBV icon

Ariadne Wealth Management’s AbbVie ABBV Stock Holding History

Ariadne Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Sell
4,667
-352
-7% -$78.1K 0.46% 50
2025
Q4 		$1.15M Sell
5,019
-578
-10% -$132K 0.48% 46
2025
Q3 		$1.3M Sell
5,597
-253
-4% -$51.5K 0.58% 39
2025
Q2 		$1.19M Sell
5,850
-188
-3% -$34.9K 0.57% 44
2025
Q1 		$1.12M Buy
6,038
+100
+2% +$19.4K 0.59% 44
2024
Q4 		$1.14M Buy
5,938
+29
+0.5% +$5.33K 0.52% 48
2024
Q3 		$1.19M Buy
+5,909
New +$1.1M 0.65% 36

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariadne Wealth Management's ABBV Position: Q1 2026 in Review

Ariadne Wealth Management reduced its AbbVie (ABBV) stake by 7% in Q1 2026, selling an estimated $78.1K and leaving 4,667 shares worth $1.02M. The position accounts for 0.46% of the portfolio, ranked #50.

Ariadne Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.3M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Ariadne Wealth Management held 4,667 shares of AbbVie worth $1.02M as of Q1 2026.
  • Ariadne Wealth Management sold 352 AbbVie shares in Q1 2026, an estimated $78.1K.
  • AbbVie made up 0.46% of Ariadne Wealth Management's portfolio in Q1 2026, its #50 holding.
  • Ariadne Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Ariadne Wealth Management's AbbVie position peaked at $1.3M in Q3 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ariadne Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.